"CARDIOLOGÍA - CIRUGIA CARDIOVASCULAR - CLÍNICA MÉDICA - DIABETOLOGÍA - GASTROENTEROLOGÍA - GERONTOLOGÍA - LABORATORIO DE ANALISIS CLINICOS - NEUROLOGÍA - NUTRICIÓN - OFTALMOLOGÍA - ONCOLOGÍA - PSICOLOGÍA - PSICOPEDAGOGÍA."

During the past decade, Centro Cardiovascular Salta conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 5 clinical trials were completed, i.e. on average, 83.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centro Cardiovascular Salta" #1 sponsor was "Boehringer Ingelheim" with 3 trials, followed by "Eli Lilly and Company" with 2 trials sponsored, "Pfizer" with 2 trials sponsored, "Brazilian Clinical Research Institute" with 1 trials sponsored and "Fundacion GESICA" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centro Cardiovascular Salta" #1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator and "Brigham and Women's Hospital" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Centro Cardiovascular Salta" are "Atrial Fibrillation" (2 trials), "Cardiovascular Disease" (2 trials), "Heart Failure" (2 trials), "Atrial Flutter" (1 trials) and "Diabetes Mellitus, Type 2" (1 trials). Many other conditions were trialed in "Centro Cardiovascular Salta" in a lesser frequency.

Most popular intervention types in "Centro Cardiovascular Salta" are "Drug" (9 trials), "Other" (2 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Empagliflozin" (2 trials), "bococizumab (PF-04950615)" (2 trials), "K-877" (1 trials) and "LY3819469" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centro Cardiovascular Salta" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Centro Cardiovascular Salta". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Centro Cardiovascular Salta, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Centro Cardiovascular Salta, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".